Jiawei Xiaoyao San in treatment of anxiety disorder and anxiety: A review.
10.1016/j.chmed.2022.12.007
- Author:
Jiaqi XIE
1
;
Dandan XU
1
;
Can WANG
1
;
Jianmei HUANG
1
Author Information
1. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.
- Publication Type:Review
- Keywords:
Jiawei Xiaoyao San;
anxiety disorder;
anxiolytic activity
- From:
Chinese Herbal Medicines
2023;15(2):214-221
- CountryChina
- Language:English
-
Abstract:
Jiawei Xiaoyao San (JWXYS) has shown excellent clinical efficacy in anxiety disorder, but has not yet attracted widespread attention. The animal experiments, clinical trials and mechanism studies of JWXYS were reviewed in this article, which may provide a reference for developing new anxiolytic drugs based on this prescription. The literature was searched in PubMed and CNKI and the documents written in English or with English abstracts were selected. JWXYS could reduce the anxiety symptoms of patients alone and reduce the adverse reactions when it is used in combination with other drugs in the clinic. In preclinical studies, JWXYS also showed therapeutic effects in reducing anxiety-like behavior. The mechanisms may include improving the hypothalamic-pituitaryadrenal (HPA) axis and hormone disorders, increasing neurotransmitter content, neurogenesis, and regulating the synthesis of related enzymes. This article shows that JWXYS could effectively treat anxiety disorders by regulating the central nervous system. In the future, with the participation of more researchers, it is expected to develop innovative drugs for the treatment of anxiety disorders based on JWXYS.
